ArticleInternational ophthalmology2026
Epithelial thickness gradients as a diagnostic biomarker for early-stage keratoconus.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate peripheral-central epithelial thickness (ET) gradients in eyes with keratoconus and regular astigmatism, and to determine their potential utility as a non-invasive biomarker for disease detection in early-stage keratoconus.
methodsThis retrospective cross-sectional analyzed ET with spectral-domain OCT at the cone apex and at 3 mm in the superior, temporal, nasal, and inferior directions. Epithelial thickness gradients (ΔET) were calculated as the difference between peripheral and central ET. Statistical comparisons were performed using non-parametric tests, with significance set at p < 0.05.
resultsA total of 396 eyes (208 keratoconus, 188 regular astigmatism) were analyzed. Central ET was significantly reduced in KC (38.55 ± 5.42 µm) vs controls (48.78 ± 3.94 µm; p < 0.001). While peripheral thickness showed minor differences, the ET gradients (ΔET) were markedly steeper in KC across all quadrants (temporal, superior, nasal, inferior, p < 0.001). Within Stage I KC, eyes with more advanced disease exhibited steeper ΔET values, particularly in the nasal and temporal directions. Mean ΔET, demonstrated significant differences between KC (8.43 ± 4.97 µm) and controls (- 1.55 ± 1.77 µm; p < 0.001), and correlated positively with steep keratometry (r = 0.521, p < 0.001) and negatively with thinnest corneal thickness (TCT) (r = - 0.641, p < 0.001).
conclusionΔET is markedly steeper in keratoconus than in regular astigmatism-even in Stage I-and correlates with steep keratometry and TCT. With areas under the curves (AUCs) up to 0.976, ΔET provides a rapid, non-invasive epithelial-based biomarker for early detection and staging of keratoconus. Its utility for monitoring progression remains to be established in prospective longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.